Latest videos


Meet Cait, age 33, from Phoenix, Arizona. After coming home from the gym, Cait felt a sizable lump near her chest while in the shower. She knew immediately something was wrong and fought to be seen by her doctors, who ultimately diagnosed her with stage IV metastatic breast cancer (MBC). Cait hopes to bring more awareness to MBC and the reality that many women diagnosed with the condition face every day by sharing her story. Cait’s story is featured as part of the #ThisIsMBC Imagine campaign, brought to you by and in collaboration with METAvivor and Eisai Inc.
To join the conversation, follow #ThisIsMBC on Twitter, Instagram, and Facebook.
To learn more about MBC, please visit: www.metavivor.org or www.mbcinfocenter.com
Licensed music:
GYLV4U6VFYVKWFYK
4XOEWQQOPQBJQZM6
W7QJRXOB0QVSL6BM
YCYQXVSBPQEII9OF


To mark the beginning of Breast Cancer Awareness month, Dr. Marisa Weiss shares a checklist for women on how to identify your own breast cancer risk and the steps you can take to reduce it.
» Subscribe to TODAY: http://on.today.com/SubscribeToTODAY
» Watch the latest from TODAY: http://bit.ly/LatestTODAY
About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website: http://on.today.com/ReadTODAY
Find TODAY on Facebook: http://on.today.com/LikeTODAY
Follow TODAY on Twitter: http://on.today.com/FollowTODAY
Follow TODAY on Instagram: http://on.today.com/InstaTODAY
» Stream TODAY All Day: https://www.today.com/allday
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#breastcancer #health #womenshealth


Triple-Negative Breast Cancer (TNBC) is called “triple negative” because there are three specific kinds of receptors that were not found when your tumor was tested. The tumor has no receptors for estrogen, progesterone, or HER2. This brief animated video provides an overview of TNBC and the types of therapy that may be used to treat it.
Please talk with your doctor and see the NCCN Guidelines for Patients: Invasive Breast Cancer and the NCCN Guidelines for Patients: Metastatic Breast Cancer for more information. https://www.nccn.org/breast-cancer-resources
This video is for informational purposes only and is not intended to be a substitute for medical advice. Talk with your doctor to determine the right course of treatment for you.
Supporters:
This video is presented with support from the NCCN Foundation and by contributions from the corporate supporter of this video, Pfizer Inc.
NCCN Guidelines for Patients are developed independently and corporate supporters do not participate in their development.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.NCCN.org/ for more information.
Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCN....video?sub_confirmati
Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/


We teach you why HER2-positive breast cancers are more threatening and educate you about new therapies such as targeted immunotherapy and neoadjuvant chemotherapy.
VISIT THE BREAST CANCER SCHOOL FOR PATIENTS:
http://www.breastcancercourse.org
LIST OF QUESTIONS FOR YOUR DOCTORS:
http://www.breastcancercourse.org/breast-health-updates-latest-videos/
FOLLOW US:
Facebook: https://www.facebook.com/Breas....t-Cancer-School-for-
_____________________________
Questions for your Breast Surgeon and Medical Oncologist:
1. What is HER2-Positive breast cancer?
2. Will I need Chemo and Targeted Therapy?
3. What are the benefits of Neoadjuvant Chemo?
4. Isn’t Neoadjuvant Chemo recommended more now?
5. Should I consider a Clinical Trial?
6. What is “HER2-Positive” breast cancer?
“HER2-Positive” breast cancers are fast growing tumors that more frequently spread beyond the breast to other parts of the body. Because of this, they are a bigger threat to your life than most other types of cancers with different receptor patterns. These cancers are called “HER2-positive” because they have too many HER2 protein receptors on their surface. These tiny proteins act like “light switches” to turn cancer cell growth “on.” Chemotherapy, combined with new, “targeted” drugs, are very effective against HER2-positive breast cancer and are a leap forward in breast cancer care.
Your Breast Surgeon will know your “receptor pattern” within days after your initial breast biopsy. These results are often not communicated to you early on in your decision process. Although only 20% of breast cancers are “HER2-positive,” it is imperative that you specifically ask your surgeon immediately, and well before surgery, “What are my receptor results?” Take our lesson on “My Tumor Receptors” to learn more.
Treated with Chemo and “Targeted Therapy”
HER2 Receptor Positive (HER2+) tumors are incredibly responsive to chemotherapy when paired with new breakthrough drugs that target these cancers, such as Herceptin and Perjeta. The same holds true if a HER2+ tumor is also Estrogen Receptor positive (ER+). HER2+ tumors are more aggressive cancers, but we now can treat them more effectively, than in the past, with chemotherapy and “targeted immunotherapy” drugs that are designed to destroy them. Everyone with a HER2+ tumor larger than 5mm (1/4 inch) and in good health is considered for chemotherapy and targeted therapy.
Unfortunately, studies have shown that many patients are not offered these standard of care, life-saving “targeted drugs” along with chemotherapy. You will make better treatment choices when you are well informed about HER2 therapies before meeting with your medical oncologist. You must inquire about Herceptin, Perjeta, and other “anti-HER2 drugs” that may be of benefit to you.
Ask about the benefits of “Neoadjuvant Chemo”
What is often overlooked are the benefits of offering neoadjuvant chemotherapy for patients with HER2-Positive, “Early-Stage” (1 & 2) breast cancers. There are distinct advantages (listed below) to having chemotherapy before surgery instead of afterwards. The decision to consider neoadjuvant chemotherapy always begins with your breast surgeon. Breast surgeons choose the initial direction of your entire breast cancer treatment plan. You must address this “cutting edge” treatment option well before surgery to benefit from neoadjuvant chemotherapy. Do not be afraid to ask. This is a very important question. Learn more about “Neoadjuvant Chemotherapy“ by taking our video lesson on the topic.
The Potential Benefits of Neoadjuvant Chemo:
*Begin life-saving chemotherapy earlier
*Reduce the need for a mastectomy
*Improve lumpectomy cosmetic outcomes
*Reduce the need for an “Axillary Dissection”
*Allows more time for BRCA genetic testing
*More time to think about “lumpectomy vs. mastectomy”
*Shows your cancer team if the chemo is working
*Can possibly eliminate all cancer cells before surgery
*Reduces the need for radiation after a mastectomy
Ask if you might benefit from a Clinical Trial.
New therapies must be studied in clinical trials to make sure they are safe and effective at treating breast cancer. HER2-positive breast cancers are currently the focus of intense clinical research. New drug treatments are rapidly being developed for this aggressive cancer. Less than 5% of all patients with breast cancer participate in clinical trials. Patients with cancer willing to participate in clinical trials are essential for the advancement of breast cancer care. Ask your medical oncologist if they offer or recommend you participate in a clinical trial for your unique breast cancer situation. Learn more about “Clinicial Trials“ at the Breast Cancer School for Patients.


The rate of breast cancer has increased exponentially in the last decade and the onset is much earlier than before.
A simple X ray of the breasts called mammogram will make sure there are no precancerous lesions in the breast and if there is, this could easily be treated at an early stage.
On this woman’s day, if every man can make sure that their sister, mother and women in their circle get a mammogram when they are between 40-45 years of age, this can be easily preventable
---
Dr. Palaniappan Manickam MD, MPH
Internal Medicine | Gastroenterology | Epidemiologist
---
For Tamil videos, please subscribe to my Tamil channel: https://www.youtube.com/channe....l/UCYxezj89xof3XRLFq
Like us on Facebook: https://www.facebook.com/Dr-Pal-102856268051377
Follow us on Instagram: https://www.instagram.com/dr.pal.manickam/
Follow us on Twitter: https://twitter.com/drpal_manickam
Join us on Telegram: https://t.me/Ask_Doc_Pal
Email: askdocpal@gmail.com
If you want to donate to AISHWARYAM TRUST, here are the details.
Website: https://aishwaryamtrust.com/


Join UCLA breast surgeon Jennifer Baker, MD, for an overview of new trends in breast cancer surgery, and how advancing knowledge in tumor biology allows surgeons to perform highly individualized and minimally invasive surgery for breast cancer. https://www.uclahealth.org/breasthealth/


We teach you to about breast cancer tumor receptors and why they are important in your breast cancer treatment. Chemotherapy and hormonal therapy are based on your receptor pattern.
VISIT THE BREAST CANCER SCHOOL FOR PATIENTS:
http://www.breastcancercourse.org
LIST OF QUESTIONS FOR YOUR DOCTORS:
http://www.breastcancercourse.org/breast-health-updates-latest-videos/
FOLLOW US:
Facebook: https://www.facebook.com/Breas....t-Cancer-School-for-
_________________________________
Questions for your Breast Surgeon and Medical Oncologist:
1. What receptors do my tumor have?
2. What type of treatment do they suggest I will need?
3. May I have a copy of all my pathology reports?
4. Do my receptors already suggest I need chemotherapy?
5. Do my receptors show I will need hormonal therapy?
6. Would I benefit from neoadjuvant chemotherapy?
What are Breast Cancer Receptors?
Once a breast biopsy is determined to be an invasive by a pathologist under the microscope, they will automatically run at least three more tests on the same tissue to determine what “receptors” are present. Receptors are tiny proteins on the surface of the cells that act like “light switches” that can turn cancer cell growth “on” or “off.” The Estrogen receptor (ER), Progesterone receptor (PR), and HER2 receptor results are incredibly important for you to know and understand. Receptors are different than “grade” and “stage” as outlined in the diagram below. All are different pieces of the breast cancer puzzle that your physicians will assemble to determine the best therapy for you. In the case of receptors, these are key determinants as to whether you will or will not benefit from hormonal therapy (pills) or chemotherapy. The receptors involving a precancerous lesion such as DCIS have different implications and are addressed in our DCIS course.
Receptors that suggest Hormonal Therapy
Estrogen Receptor Positive (ER+) tumors are always treated with hormonal therapy. Usually these types of medications (pills) are taken for a total of 5 to 10 years. It is still possible that one may need chemotherapy in addition to hormonal therapy. If you are Progesterone Receptor Positive (PR+) then you will likely need hormonal therapy, even if you are ER-. The Estrogen Receptor plays a much more important role in cancer care than the Progesterone Receptor.
Receptors that suggest Chemotherapy
Determining if you need chemotherapy is a very complex decision process and is primarily driven by your medical oncologist. Your “receptor pattern” is a key piece of information that is known early in your breast cancer journey. In about 30% of patients with an invasive breast cancer, the receptor pattern alone can strongly suggest that chemotherapy will be needed, regardless of what is found at surgery. We list a few of the more common “chemotherapy receptor patterns” below. Many factors, including a large cancer and cancer that is present in the lymph nodes, also point someone towards chemotherapy. Take our video lesson on “Will I Need Chemotherapy“ (here). Often if someone needs chemotherapy, they will likely benefit also from hormonal therapy after chemotherapy if their estrogen receptor is positive.
Estrogen Receptor Negative (ER-) tumors do not respond to anti-estrogen oral medications that are essential for treating estrogen receptor positive (ER+) tumors. Quite simply, patients with ER negative tumors will benefit from chemotherapy if they are healthy enough to tolerate it. ER negative tumors are more aggressive cancers, but respond very well to chemotherapy. This includes “triple negative” breast cancers. Progesterone Receptors (PR) play a much smaller role than estrogen or HER2 receptors and are not addressed here.
HER2 Receptor Positive (HER2+) tumors are very responsive to chemotherapy when paired with new breakthrough drugs that target these tumors, such as Herceptin and Perjeta. The same holds true if a HER2-positive tumor is also ER positive. Take our “HER2-Positive“ video lesson to learn more (here). HER2-positive tumors are more aggressive cancers, but we now can treat them more effectively with chemotherapy and “targeted immunotherapy” drugs that are designed to destroy HER2-positive cancers.
“Triple Negative” (ER-)(PR-)(HER2-) tumors are also fast growing tumors that are usually treated with a specific chemotherapy regimen. These tumors are not responsive to hormonal therapy at all, but are sensitive to chemotherapy. If you have “Triple Negative Breast Cancer“ review our video lesson (here).
Take home message:
Make sure to ask for a copy of the pathology report from your biopsy. Ask your breast surgeon and medical oncologist to explain to you what your receptors mean regarding your treatment. Sometimes the HER2 receptor results can take up to two weeks to become finalized. Inquire early on with your physicians about your benefit from hormonal therapy and/or chemotherapy.


Not all breast cancer begins with a lump. Learn the unusual signs of inflammatory breast cancer that include a breast that is red and hardened, feels heavy to the touch and is enlarged.
Learn more at https://health.osu.edu/
Learn more about inflammatory breast cancer at https://cancer.osu.edu/for-pat....ients-and-caregivers
#inflammatorybreastcancer
#TheJames


Breast Cancer Symptoms and signs are reviewed and explained. What is normal and what isn't? It's always best to do a monthly self-breast exam to get to know your breast tissue so you can monitor for any new changes. The 12 breast cancer signs are explained. If any symptoms are found or other concerns, then it's always best to check with a doctor.
-------------------------------------------------------------------------------------------------------
Finding my channel and content helpful and want to support my channel? Your donations are greatly appreciated and can be made here: http://buymeacoffee.com/cancerrehabpt
Join us on Instagram: @cancerrehabpt
https://www.instagram.com/cancerrehabpt/
Check out my website for more information:
http://cancerrehabpt.com
-------------------------------------------------------------------------------------------------------
Use code KELLY10 for 10% off the BEST, medical-quality lymphedema products at BrightLife Direct (*Shipping is free in the US*): https://bit.ly/3udwb1t
For my favorite, go-to products related to management and wellness for lymphatic health and oncology, checkout my storefront!: http://amazon.com/shop/cancerrehabpt
Disclosure: Links included in this description may be affiliate links. If you purchase a product or service with the links that I provide I may receive a small commission. There is no additional charge to you. Thank you for your support!
DISCLAIMER
THE CONTENT OF THIS VIDEO DOES NOT REPLACE THE CARE OF PHYSICAL THERAPISTS OR OTHER HEALTHCARE PROFESSIONALS. THIS VIDEO CONTENT IS IN NO WAY TO BE CONSTRUED OR SUBSTITUTED AS PHYSICAL THERAPY OR ANY OTHER TYPE MEDICAL ADVICE, BUT IS FOR GENERAL EDUCATION aND DEMONSTRATION ONLY. THESE MOVES MAY NOT BE APPROPRIATE FOR YOUR SPECIFIC SITUATION, SO GET APPROVAL AND GUIDANCE FROM YOUR OWN HEALTHCARE PROVIDER BEFORE BEGINNING. PERFORM AT YOUR OWN RISK. DON'T USE THIS CONTENT TO SELF-DIAGNOSE OR SELF-TREAT ANY HEALTH, MEDICAL, OR PHYSICAL CONDITION. YOU AGREE TO HOLD HARMLESS AND INDEMNIFY CANCER REHAB PT LLC FOR ANY AND ALL LOSSES INJURIES, OR DAMAGES RESULTING FROM ANY AND ALL CLAIMS THAT ARISE FROM YOUR USE OR MISUSE OF THIS CONTENT. ALL CONTENT OR RECOMMENDATIONS ON THE COMPANY’S WEBSITE, SOCIAL MEDIA, BLOG, OR EMAIL SERIES AND CANCER REHAB PT LLC's COMMENTS ARE EXPRESSIONS OF OPINION ONLY.


Dr. Sandhya Pruthi, Mayo Clinic Breast Clinic physician and principal investigator, shares common types of breast cancer including ductal and lobular breast cancer, and invasive and non-invasive breast cancer. Learn more about breast cancer care at Mayo Clinic: https://mayocl.in/2v60NoX
To request an appointment, visit : https://mayocl.in/2QwVBoc
Connect with us:
Twitter @mayoclinic - https://twitter.com/mayoclinic
Facebook @mayoclinic - https://www.facebook.com/MayoClinic/
Instagram @mayoclinic - https://www.instagram.com/mayoclinic/